Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Ziprasidone Hydrochloride Capsules
- Product Name
- 卓乐定
- Approval Number
- 国药准字HJ20160411
- Approval Date
- Sep 30, 2024
NMPA
Ziprasidone Hydrochloride Capsules
- Product Name
- 卓乐定
- Approval Number
- 国药准字HJ20160410
- Approval Date
- Sep 30, 2024
NMPA
Doxazosin Mesylate Extended Release Tablets
- Product Name
- 可多华
- Approval Number
- 国药准字HJ20170175
- Approval Date
- Jul 4, 2023
NMPA
Doxazosin Mesylate Extended Release Tablets
- Product Name
- 可多华
- Approval Number
- 国药准字HJ20170174
- Approval Date
- Jul 4, 2023
NMPA
Ziprasidone Hydrochloride Capsules
- Product Name
- 卓乐定
- Approval Number
- H20160411
- Approval Date
- Jan 2, 2020
NMPA
Ziprasidone Hydrochloride Capsules
- Product Name
- 卓乐定
- Approval Number
- H20160410
- Approval Date
- Jan 2, 2020
NMPA
Clinical Trials
No trials found
News
No news found